{"Ticker": "ZBH", "Company": "Zimmer Biomet", "Sector": "Health Care", "Updated": "2023-01-05", "Rating": [{"Date": "2023-01-05", "Rating": "Upgrade", "Organization": "Raymond James", "Rating_Change": "Mkt Perform to Outperform", "Target_Change": "$144"}, {"Date": "2023-01-03", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": "$130"}, {"Date": "2022-11-23", "Rating": "Upgrade", "Organization": "Wells Fargo", "Rating_Change": "Underweight to Equal Weight", "Target_Change": ""}, {"Date": "2022-10-18", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Underweight", "Target_Change": "$104"}, {"Date": "2022-10-12", "Rating": "Initiated", "Organization": "Jefferies", "Rating_Change": "Underperform", "Target_Change": "$95"}, {"Date": "2022-05-27", "Rating": "Downgrade", "Organization": "Needham", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2022-04-13", "Rating": "Downgrade", "Organization": "Truist", "Rating_Change": "Buy to Hold", "Target_Change": "$128 to $142"}, {"Date": "2022-04-01", "Rating": "Downgrade", "Organization": "Citigroup", "Rating_Change": "Buy to Neutral", "Target_Change": "$125.15 to $135"}, {"Date": "2022-03-02", "Rating": "Resumed", "Organization": "BofA Securities", "Rating_Change": "Underperform", "Target_Change": "$120"}, {"Date": "2022-03-02", "Rating": "Downgrade", "Organization": "Loop Capital", "Rating_Change": "Buy to Hold", "Target_Change": "$130"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Wells Fargo", "Rating_Change": "Underweight", "Target_Change": "$124 to $111"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "UBS", "Rating_Change": "Neutral", "Target_Change": "$130 to $121"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Truist", "Rating_Change": "Buy", "Target_Change": "$145 to $128"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Stifel", "Rating_Change": "Buy", "Target_Change": "$178 to $130"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$140 to $125"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "JP Morgan", "Rating_Change": "Neutral", "Target_Change": "$150 to $114"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "JMP Securities", "Rating_Change": "Mkt Outperform", "Target_Change": "$175 to $145"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Deutsche Bank", "Rating_Change": "Hold", "Target_Change": "$140 to $121"}, {"Date": "2022-02-08", "Rating": "Reiterated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$150 to $129"}, {"Date": "2022-02-08", "Rating": "Downgrade", "Organization": "Canaccord Genuity", "Rating_Change": "Buy to Hold", "Target_Change": "$165 to $125"}, {"Date": "2022-02-02", "Rating": "Downgrade", "Organization": "UBS", "Rating_Change": "Buy to Neutral", "Target_Change": "$172 to $130"}, {"Date": "2022-01-19", "Rating": "Downgrade", "Organization": "Wells Fargo", "Rating_Change": "Equal Weight to Underweight", "Target_Change": "$170 to $124"}, {"Date": "2022-01-10", "Rating": "Downgrade", "Organization": "Mizuho", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2022-01-07", "Rating": "Downgrade", "Organization": "Morgan Stanley", "Rating_Change": "Overweight to Equal-Weight", "Target_Change": "$165 to $145"}, {"Date": "2022-01-04", "Rating": "Downgrade", "Organization": "Piper Sandler", "Rating_Change": "Overweight to Neutral", "Target_Change": "$185 to $135"}, {"Date": "2021-12-10", "Rating": "Initiated", "Organization": "RBC Capital Mkts", "Rating_Change": "Sector Perform", "Target_Change": "$140"}, {"Date": "2021-12-09", "Rating": "Downgrade", "Organization": "Needham", "Rating_Change": "Strong Buy to Buy", "Target_Change": "$175 to $158"}, {"Date": "2021-12-07", "Rating": "Initiated", "Organization": "Loop Capital", "Rating_Change": "Buy", "Target_Change": "$165"}, {"Date": "2021-11-23", "Rating": "Downgrade", "Organization": "Argus", "Rating_Change": "Buy to Hold", "Target_Change": ""}, {"Date": "2021-09-14", "Rating": "Resumed", "Organization": "Raymond James", "Rating_Change": "Mkt Perform", "Target_Change": ""}, {"Date": "2021-05-25", "Rating": "Initiated", "Organization": "Barclays", "Rating_Change": "Overweight", "Target_Change": "$210"}, {"Date": "2021-04-09", "Rating": "Upgrade", "Organization": "Northland Capital", "Rating_Change": "Market Perform to Outperform", "Target_Change": "$165 to $2300"}, {"Date": "2021-01-04", "Rating": "Upgrade", "Organization": "Evercore ISI", "Rating_Change": "In-line to Outperform", "Target_Change": "$175"}, {"Date": "2020-12-18", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Strong Buy", "Target_Change": "$168 to $185"}, {"Date": "2020-10-20", "Rating": "Initiated", "Organization": "Northland Capital", "Rating_Change": "Market Perform", "Target_Change": "$150"}, {"Date": "2020-09-11", "Rating": "Initiated", "Organization": "Wolfe Research", "Rating_Change": "Outperform", "Target_Change": "$174"}, {"Date": "2020-08-05", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Strong Buy", "Target_Change": "$148 to $162"}, {"Date": "2020-04-28", "Rating": "Downgrade", "Organization": "Guggenheim", "Rating_Change": "Buy to Neutral", "Target_Change": ""}, {"Date": "2020-04-09", "Rating": "Downgrade", "Organization": "Evercore ISI", "Rating_Change": "Outperform to In-line", "Target_Change": ""}, {"Date": "2020-04-07", "Rating": "Reiterated", "Organization": "Needham", "Rating_Change": "Strong Buy", "Target_Change": "$189 to $153"}, {"Date": "2020-03-05", "Rating": "Initiated", "Organization": "Citigroup", "Rating_Change": "Buy", "Target_Change": "$168"}, {"Date": "2020-02-13", "Rating": "Initiated", "Organization": "Goldman", "Rating_Change": "Buy", "Target_Change": "$177"}, {"Date": "2020-01-08", "Rating": "Initiated", "Organization": "SunTrust", "Rating_Change": "Buy", "Target_Change": "$179"}, {"Date": "2020-01-07", "Rating": "Upgrade", "Organization": "Piper Sandler", "Rating_Change": "Neutral to Overweight", "Target_Change": "$140 to $170"}, {"Date": "2020-01-07", "Rating": "Upgrade", "Organization": "Piper Jaffray", "Rating_Change": "Neutral to Overweight", "Target_Change": "$140 to $170"}]}